Whitener Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $712K | Hold |
7,873
| – | – | 0.15% | 107 |
|
|
2026
Q1 | $630K | Sell |
7,873
-475
| -6% | -$39.2K | 0.14% | 103 |
|
|
2025
Q4 | $712K | Sell |
8,348
-1,075
| -11% | -$88.2K | 0.16% | 95 |
|
|
2025
Q3 | $733K | Buy |
9,423
+75
| +0.8% | +$5.86K | 0.18% | 93 |
|
|
2025
Q2 | $731K | Sell |
9,348
-125
| -1% | -$9.32K | 0.19% | 84 |
|
|
2025
Q1 | $687K | Sell |
9,473
-225
| -2% | -$16.1K | 0.19% | 87 |
|
|
2024
Q4 | $718K | Sell |
9,698
-725
| -7% | -$50.7K | 0.2% | 86 |
|
|
2024
Q3 | $688K | Sell |
10,423
-2,325
| -18% | -$169K | 0.2% | 91 |
|
|
2024
Q2 | $1.18M | Sell |
12,748
-175
| -1% | -$15.5K | 0.36% | 59 |
|
|
2024
Q1 | $1.23M | Sell |
12,923
-267
| -2% | -$22.4K | 0.4% | 55 |
|
|
2023
Q4 | $1.01M | Sell |
13,190
-1,126
| -8% | -$78.3K | 0.36% | 57 |
|
|
2023
Q3 | $992K | Sell |
14,316
-510
| -3% | -$41K | 0.4% | 56 |
|
|
2023
Q2 | $1.4M | Sell |
14,826
-410
| -3% | -$35.6K | 0.54% | 47 |
|
|
2023
Q1 | $1.26M | Sell |
15,236
-2,393
| -14% | -$188K | 0.53% | 48 |
|
|
2022
Q4 | $1.32M | Sell |
17,629
-200
| -1% | -$15.4K | 0.57% | 47 |
|
|
2022
Q3 | $1.47M | Sell |
17,829
-947
| -5% | -$91.1K | 0.7% | 40 |
|
|
2022
Q2 | $1.78M | Sell |
18,776
-200
| -1% | -$20.7K | 0.8% | 35 |
|
|
2022
Q1 | $2.23M | Sell |
18,976
-895
| -5% | -$100K | 0.84% | 28 |
|
|
2021
Q4 | $2.57M | Sell |
19,871
-394
| -2% | -$46K | 0.92% | 29 |
|
|
2021
Q3 | $1.85M | Buy |
20,265
+150
| +0.7% | +$17.1K | 0.85% | 28 |
|
|
2021
Q2 | $2.08M | Sell |
20,115
-125
| -0.6% | -$11.8K | 0.83% | 32 |
|
|
2021
Q1 | $1.69M | Sell |
20,240
-25
| -0.1% | -$2.11K | 0.73% | 36 |
|
|
2020
Q4 | $1.85M | Sell |
20,265
-3,895
| -16% | -$323K | 0.85% | 28 |
|
|
2020
Q3 | $1.93M | Sell |
24,160
-1,070
| -4% | -$83.5K | 0.93% | 28 |
|
|
2020
Q2 | $1.74M | Buy |
25,230
+300
| +1% | +$21.3K | 0.91% | 28 |
|
|
2020
Q1 | $1.57M | Buy |
24,930
+225
| +0.9% | +$16.2K | 1.01% | 27 |
|
|
2019
Q4 | $1.92M | Buy |
24,705
+1,695
| +7% | +$132K | 1% | 24 |
|
|
2019
Q3 | $1.69M | Sell |
23,010
-30
| -0.1% | -$2.11K | 0.93% | 26 |
|
|
2019
Q2 | $1.42M | Buy |
23,040
+2,820
| +14% | +$171K | 0.81% | 31 |
|
|
2019
Q1 | $1.29M | Sell |
20,220
-3,300
| -14% | -$188K | 0.84% | 30 |
|
|
2018
Q4 | $1.2M | Buy |
23,520
+4,650
| +25% | +$235K | 0.88% | 29 |
|
|
2018
Q3 | $1.09M | Sell |
18,870
-195
| -1% | -$9.54K | 0.72% | 33 |
|
|
2018
Q2 | $925K | Sell |
19,065
-150
| -0.8% | -$7K | 0.73% | 36 |
|
|
2018
Q1 | $893K | Buy |
19,215
+75
| +0.4% | +$3.26K | 0.68% | 36 |
|
|
2017
Q4 | $719K | Buy |
+19,140
| New | +$702K | 0.62% | 45 |
|
Other funds holding EW
Whitener Capital Management's EW Position: Q2 2026 in Review
Whitener Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 7,873 shares worth $712K. The position accounts for 0.15% of the portfolio, ranked #107.
Whitener Capital Management first reported a position in EW in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.57M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Whitener Capital Management held 7,873 shares of Edwards Lifesciences worth $712K as of Q2 2026.
- Whitener Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.15% of Whitener Capital Management's portfolio in Q2 2026, its #107 holding.
- Whitener Capital Management first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 35 quarters since.
- Whitener Capital Management's Edwards Lifesciences position peaked at $2.57M in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Whitener Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.